T2 Biosystems (TTOO) Competitors $0.45 -0.02 (-3.59%) (As of 10:02 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TTOO vs. XAIR, SURG, POCI, CODX, ALUR, BSGM, DRIO, IRIX, STIM, and NXGLShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Beyond Air (XAIR), SurgePays (SURG), Precision Optics (POCI), Co-Diagnostics (CODX), Allurion Technologies (ALUR), BioSig Technologies (BSGM), DarioHealth (DRIO), IRIDEX (IRIX), Neuronetics (STIM), and NEXGEL (NXGL). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. Beyond Air SurgePays Precision Optics Co-Diagnostics Allurion Technologies BioSig Technologies DarioHealth IRIDEX Neuronetics NEXGEL T2 Biosystems (NASDAQ:TTOO) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Do insiders & institutionals believe in TTOO or XAIR? 23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 0.1% of T2 Biosystems shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, TTOO or XAIR? T2 Biosystems has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Do analysts recommend TTOO or XAIR? T2 Biosystems presently has a consensus price target of $5.00, indicating a potential upside of 1,023.09%. Beyond Air has a consensus price target of $3.67, indicating a potential upside of 628.96%. Given T2 Biosystems' higher possible upside, equities research analysts plainly believe T2 Biosystems is more favorable than Beyond Air.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is TTOO or XAIR more profitable? T2 Biosystems has a net margin of -563.16% compared to Beyond Air's net margin of -2,369.17%. T2 Biosystems' return on equity of 0.00% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% Beyond Air -2,369.17%-227.29%-106.51% Does the media prefer TTOO or XAIR? In the previous week, T2 Biosystems and T2 Biosystems both had 5 articles in the media. Beyond Air's average media sentiment score of 0.55 beat T2 Biosystems' score of 0.50 indicating that Beyond Air is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment T2 Biosystems 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Beyond Air 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in TTOO or XAIR? T2 Biosystems received 358 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 64.44% of users gave T2 Biosystems an outperform vote. CompanyUnderperformOutperformT2 BiosystemsOutperform Votes40664.44% Underperform Votes22435.56% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Which has better earnings and valuation, TTOO or XAIR? T2 Biosystems has higher revenue and earnings than Beyond Air. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.19M1.30-$50.08MN/AN/ABeyond Air$1.16M31.30-$60.24M-$1.41-0.36 SummaryBeyond Air beats T2 Biosystems on 9 of the 16 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.37M$4.43B$5.07B$8.80BDividend YieldN/A36.79%4.99%4.07%P/E RatioN/A13.5789.5613.60Price / Sales1.3044.221,224.8087.40Price / CashN/A52.2739.4536.27Price / Book-0.805.776.976.33Net Income-$50.08M$13.76M$119.04M$225.93M7 Day Performance-14.38%-0.99%-1.78%-0.96%1 Month Performance-68.87%0.71%-3.59%1.06%1 Year Performance-88.28%51.46%31.64%26.59% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 Biosystems2.4481 of 5 stars$0.45-3.6%$5.00+1,023.1%-88.3%$9.37M$7.19M0.00180XAIRBeyond Air4.2935 of 5 stars$0.50+2.3%$3.67+629.0%-69.1%$36.31M$1.16M0.0070Gap DownSURGSurgePays3.787 of 5 stars$1.72+17.8%$9.00+423.3%-77.0%$34.68M$137.14M-1.4922POCIPrecision Optics0.8663 of 5 stars$5.35+0.6%N/A-11.1%$33.97M$19.10M0.0080CODXCo-Diagnostics4.3727 of 5 stars$1.04flat$1.50+44.2%-27.8%$33.21M$6.81M0.00100Short Interest ↓Gap DownALURAllurion Technologies2.7467 of 5 stars$0.50+9.1%$2.88+475.7%-88.1%$32.15M$53.47M0.00501Analyst RevisionGap UpBSGMBioSig TechnologiesN/A$1.82-2.7%N/A-45.1%$31.18M$20,000.000.0050DRIODarioHealth1.8695 of 5 stars$0.87+11.9%$4.00+358.2%-31.6%$29.77M$20.35M-0.93200IRIXIRIDEX0.6933 of 5 stars$1.740.0%$2.00+14.9%-17.1%$28.95M$51.87M0.00120STIMNeuronetics2.3981 of 5 stars$0.76-5.0%$4.67+512.4%-40.6%$23.13M$71.35M0.00180NXGLNEXGEL1.4395 of 5 stars$3.34+1.2%N/A+84.4%$22.68M$4.09M0.0010 Related Companies and Tools Related Companies Beyond Air Competitors SurgePays Competitors Precision Optics Competitors Co-Diagnostics Competitors Allurion Technologies Competitors BioSig Technologies Competitors DarioHealth Competitors IRIDEX Competitors Neuronetics Competitors NEXGEL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TTOO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.